Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union.

ABSTRACT:

Background

A Guide for Healthcare Professionals (HCP Guide) and patient alert card (PAC) for atezolizumab as additional risk minimization measures for physicians were distributed to raise awareness and help in the detection and management of immune-related adverse drug reactions.

Objectives

The main objective of this study was to assess the receipt, knowledge, and behaviors of physicians regarding the atezolizumab HCP Guide and PAC.

Methods

A multi-country, one-wave, observational, cross-sectional, web-based, self-reported physician survey was conducted to assess the level of knowledge of key messages related to immune-related adverse drug reactions summarized in the atezolizumab HCP Guide and PAC among physicians (oncologists, pulmonologists, and urologists) prescrib

SUBMITTER: Patel H 

PROVIDER: S-EPMC8668858 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature